A new study reveals that delayed REM sleep might signal an early warning of Alzheimer’s, stirring concern among those focused on proactive health measures.
Story Highlights
- REM sleep delays are linked to increased Alzheimer’s risk.
- The study suggests using REM latency as a novel biomarker.
- Research was conducted in a controlled clinical environment.
- Potential for early intervention in Alzheimer’s disease.
Groundbreaking Research on REM Sleep and Alzheimer’s
In January 2025, a pivotal study published in *Alzheimer’s and Dementia* unveiled that delays in reaching REM sleep are associated with an increased risk of Alzheimer’s disease. Conducted at the China-Japan Friendship Hospital in Beijing, researchers employed rigorous overnight polysomnography to monitor 128 participants. The findings highlight REM latency as a potential early diagnostic marker, offering a new avenue for early detection and intervention in Alzheimer’s disease.
The study’s results suggest that individuals who take longer to enter REM sleep exhibit elevated levels of toxic proteins, such as amyloid and tau, which are linked to Alzheimer’s pathology. Furthermore, these individuals show reduced levels of brain-derived neurotrophic factor (BDNF), a protein crucial for neuronal health. These insights underscore the importance of REM sleep in maintaining cognitive health and its potential role in signaling early cognitive decline.
Watch:
https://youtube.com/shorts/rj5yKfgLggA?si=l1XaMhGQ1Ah4DfP4
Meet My Healthy Doc – instant answers, anytime, anywhere.
Understanding the Implications of REM Sleep Delays
Historically, the link between sleep and Alzheimer’s has been a significant research area, with a focus on how sleep quality and duration influence disease risk. This study marks a shift by isolating REM latency as a distinct risk factor. Unlike previous research relying on self-reported data, this study provides precise neurophysiological measurements, offering a more objective assessment of sleep’s impact on brain health.
Dr. Yue Leng, the study’s senior author, emphasizes the need for further research to determine whether delayed REM sleep is a cause or a symptom of Alzheimer’s disease. The study’s findings have attracted significant media attention and interest within the neurology and sleep medicine communities, highlighting the potential for polysomnography to be integrated into Alzheimer’s risk assessment protocols.
Chat with AI for personalized sleep tips.
Potential for Transformative Alzheimer’s Intervention
If further validated, measuring REM latency could become a standard component of Alzheimer’s risk stratification. This approach could enable intervention decades before symptoms appear, fundamentally altering Alzheimer’s management from reactive treatment to proactive prevention. However, widespread clinical implementation awaits additional validation studies, as the research primarily involved a Chinese population and requires broader demographic validation.
The study opens new possibilities for sleep-targeted interventions and medications designed to normalize REM latency, creating potential therapeutic markets. While the research is promising, experts acknowledge the need for longitudinal studies to establish causality and clarify biological pathways linking REM sleep delays to Alzheimer’s pathology.
Watch:
https://youtube.com/shorts/_hfychewZw4?si=42lDzNM_3hwpK6hx
Your instant doctor companion – online 24 hours a day.
Sources:
Delayed REM Sleep Could Be an Early Sign of Alzheimer’s
Reduced Deep and REM Sleep Could Be Early Markers of Alzheimer’s
Delayed REM Sleep May Be an Early Sign of Alzheimer’s
New Alzheimer’s Warning Sign Discovered by Scientists
